Pro-Dex, Inc. (NASDAQ:PDEX) Short Interest Down 23.9% in May

Pro-Dex, Inc. (NASDAQ:PDEXGet Free Report) saw a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 6,700 shares, a decline of 23.9% from the May 15th total of 8,800 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.3% of the shares of the company are short sold.

Analyst Ratings Changes

Separately, StockNews.com raised Pro-Dex from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, June 5th.

Check Out Our Latest Report on PDEX

Pro-Dex Stock Performance

Shares of PDEX stock traded down $0.28 on Friday, hitting $19.32. The company had a trading volume of 1,836 shares, compared to its average volume of 7,832. The firm has a market cap of $66.07 million, a P/E ratio of 33.31 and a beta of 0.41. The company has a 50-day moving average price of $18.97 and a 200-day moving average price of $18.48. The company has a quick ratio of 2.08, a current ratio of 3.45 and a debt-to-equity ratio of 0.25. Pro-Dex has a twelve month low of $14.51 and a twelve month high of $22.99.

Pro-Dex (NASDAQ:PDEXGet Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.19 earnings per share (EPS) for the quarter. The business had revenue of $14.29 million during the quarter. Pro-Dex had a return on equity of 6.50% and a net margin of 4.13%.

Hedge Funds Weigh In On Pro-Dex

An institutional investor recently raised its position in Pro-Dex stock. Perritt Capital Management Inc. boosted its position in shares of Pro-Dex, Inc. (NASDAQ:PDEXFree Report) by 43.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,000 shares of the medical instruments supplier’s stock after buying an additional 1,813 shares during the period. Perritt Capital Management Inc. owned 0.18% of Pro-Dex worth $106,000 at the end of the most recent quarter. 15.28% of the stock is owned by institutional investors and hedge funds.

Pro-Dex Company Profile

(Get Free Report)

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.

Featured Stories

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.